share_log

Illumina Shares Are Trading Lower After Barclays Maintained an Underweight Rating on the Stock but Raised Its Price Target From $130 to $175. The Company on Thursday Presented at Its Inaugural Illumina Genomics Forum.

Benzinga ·  Sep 30, 2022 10:06
Illumina shares are trading lower after Barclays maintained an Underweight rating on the stock but raised its price target from $130 to $175. The company on Thursday presented at its inaugural Illumina Genomics Forum.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment